JPRN-UMIN000003680已完成2 期
Phase II study of Pemetrexed and Carboplatin plus Bevacizumab for advanced non-small cell lung cancer - Phase II study of Pemetrexed and Carboplatin plus Bevacizumab for advanced non-small cell lung cancer
ippon Medical School Hospital0 个研究点目标入组 26 人开始时间: 2010年6月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Uncontrolled infection or serious medical complications 2)massive pleural effusion or ascites(accept controrable pleural effusion with OK-432) 3)brain metastasis 4)history of severe cardiac disease 5)uncontrollable diabetes 6)recieving anticoagulant drug(except Aspirin under 324mg/day) 7)history of gross hemoptysis(>2.6ml) 8)history of severe hemosputum(over 1week, or reciving hemostatic drug) 9)uncontrollable hypertension 10)history of GI perfortion(within the last 1 year) 11)history of myocardial infarction or cerebral infarction 12)interstitial pneumonia or pulmonary fibrosis detectable on CT scan 13)history of drug-indused pneumonitis 14)the operation has been scheduled for the examination period 15)treatment history of Pemetrexed, Carboplatin, and Bevacizumab 16)severe drug allegy 17)not reciving folic acid and vitamin B12 18)active concomitant malignancy 19)history of severe mental disorder 20)now pregnant or lactation 21)judged to be not suitable by the attending physician
研究者
相似试验
已完成
2 期
Phase II study of carboplatin and pemetrexed plus bevacizumab after failure of first-line EGFR TKI therapy for non-small-cell lung cancer harboring EGFR mutation.on-squamous Non-small-cell Lung CancerJPRN-UMIN000004731Central Japan Lung Study Group27
已完成
2 期
Phase II study of Pemetrexed + Carboplatin as first line therapy for nonsquamous non-small cell lung cancer with interstitial pneumoniaJPRN-UMIN000011325Central Japan Lung Study Group (CJLSG)25
招募中
2 期
A Phase II study of Pemetrexed plus Carboplatin Plus Bevacizumab followed by maintenance Pemetrexed in patients with previously untreated stage III/IV or non-squamous non-small-cell and lung cancer.on-squamous non-small cell lung cancer (EGFR mutation status Negative)JPRN-UMIN000005991Toho University Omori Medical Center35
已完成
2 期
A Phase II study of Pemetrexed plus Carboplatin Plus Bevacizumab followed by maintenance Pemetrexed Plus Bevacizumab in patients with previously untreated stage III/IV or post-operative recurrent non-squamous non-small-cell and lung cancer.on-squamous non-small cell lung cancerJPRN-UMIN000003770Osaka Lung Cancer Study Group40
已完成
2 期
A Phase 2 study of pemetrexed and carboplatin for platinum-pretreated patients with non small cell lung cancerplatinum pretreated patients with non small cell lung cancerJPRN-UMIN000005552Osaka Prefectural Medical Center for Respiratory and Allergic deseases30